- Home
- USEG vs FGEN Comparison
USEG vs FGEN Comparison
Compare USEG & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- FGEN
- Stock Information
- Founded
- USEG 1966
- FGEN 1993
- Country
- USEG United States
- FGEN United States
- Employees
- USEG N/A
- FGEN N/A
- Industry
- USEG Oil & Gas Production
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- USEG Energy
- FGEN Health Care
- Exchange
- USEG Nasdaq
- FGEN Nasdaq
- Market Cap
- USEG 37.9M
- FGEN 33.5M
- IPO Year
- USEG N/A
- FGEN 2014
- Fundamental
- Price
- USEG $1.15
- FGEN $0.29
- Analyst Decision
- USEG Strong Buy
- FGEN Strong Buy
- Analyst Count
- USEG 2
- FGEN 1
- Target Price
- USEG $2.75
- FGEN $10.00
- AVG Volume (30 Days)
- USEG 271.6K
- FGEN 1.2M
- Earning Date
- USEG 05-08-2025
- FGEN 05-05-2025
- Dividend Yield
- USEG N/A
- FGEN N/A
- EPS Growth
- USEG N/A
- FGEN N/A
- EPS
- USEG N/A
- FGEN N/A
- Revenue
- USEG $19,343,000.00
- FGEN $29,621,000.00
- Revenue This Year
- USEG $23.82
- FGEN $232.81
- Revenue Next Year
- USEG N/A
- FGEN $9.16
- P/E Ratio
- USEG N/A
- FGEN N/A
- Revenue Growth
- USEG N/A
- FGEN N/A
- 52 Week Low
- USEG $0.81
- FGEN $0.18
- 52 Week High
- USEG $6.40
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- USEG 41.02
- FGEN 41.77
- Support Level
- USEG $1.01
- FGEN $0.23
- Resistance Level
- USEG $1.17
- FGEN $0.31
- Average True Range (ATR)
- USEG 0.11
- FGEN 0.03
- MACD
- USEG 0.02
- FGEN 0.01
- Stochastic Oscillator
- USEG 54.84
- FGEN 55.45
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.